XENOSOURCE Trademark

Trademark Overview


On Friday, July 21, 2023, a trademark application was filed for XENOSOURCE with the United States Patent and Trademark Office. The USPTO has given the XENOSOURCE trademark a serial number of 98096475. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 20, 2024. This trademark is owned by South Texas Accelerated Research Therapeutics, LLC. The XENOSOURCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; medical and scientific research services in the field of cancer diagnosis, therapy, prevention, and treatment; development of translational research tools for the collection, analysis, grooming, sale, and license of preclinical and clinical data and patient derived xenograft models related to the treatment of oncology; medical and scientific research, namely, translational research for the collection, analysis, grooming, sale, and license of preclinical and clinical data and patient derived xenograft models for the treatment of oncology
xenosource

General Information


Serial Number98096475
Word MarkXENOSOURCE
Filing DateFriday, July 21, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements


Pseudo MarkXENO SOURCE
Goods and ServicesPharmaceutical drug development services; medical and scientific research services in the field of cancer diagnosis, therapy, prevention, and treatment; development of translational research tools for the collection, analysis, grooming, sale, and license of preclinical and clinical data and patient derived xenograft models related to the treatment of oncology; medical and scientific research, namely, translational research for the collection, analysis, grooming, sale, and license of preclinical and clinical data and patient derived xenograft models for the treatment of oncology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 21, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSouth Texas Accelerated Research Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78229

Party NameSouth Texas Accelerated Research Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78229

Trademark Events


Event DateEvent Description
Monday, March 25, 2024ASSIGNED TO EXAMINER
Tuesday, July 25, 2023NEW APPLICATION ENTERED
Monday, August 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 4, 2024NON-FINAL ACTION WRITTEN
Thursday, April 4, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 18, 2024ASSIGNED TO EXAMINER
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER